References
- Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 2003;17:503–28.
- Black J, Calesnick B, Williams D, Weinstein MJ. Pharmacology of gentamicin, a new broad-spectrum antibiotic. Antimicrob Agents Chemother (Bethesda) 1963;161:138–47.
- Slavik RS, Jewesson PJ. Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic– pharmacodynamic considerations. Clin Pharmacokinet 2003;42:793–817.
- Rougier F, Corvaisier S, Ducher M, Claude D, Jelliffe RW, Maire P. PK/PD modeling of aminoglycoside nephrotoxicity. Pathol Biol (Paris) 2003;51:234–6.
- Kashuba AD, Bertino JS Jr, Nafziger AN. Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by Gram-negative organisms. Antimicrob Agents Chemother 1998;42: 1842–4.
- Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93–9.
- Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, . Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139:877–84.
- Deziel-Evans LM, Murphy JE, Job ML. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides. Clin Pharm 1986;5:319–24.
- Chung M, Costello R, Symchowicz S. Comparison of netilmicin and gentamicin pharmacokinetics in humans. Antimicrob Agents Chemother 1980;17:184–7.
- Sundin DP, Sandoval R, Molitoris BA. Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J Am Soc Nephrol 2001;12:114–23.
- Wersall J, Lundquist PG, Bjorkroth B. Ototoxicity of gentamicin. J Infect Dis 1969;119:410–6.
- Jackson GG, Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis 1971;124(Suppl):S130–7.
- Aronoff GR, Berns JS, Brier ME, Kasbekar N, Mueller BA, Pasko DA, Smoyer WE. Drug prescribing in renal failure: dosing guidelines for adults and children. 5th ed. Philadelphia: American College of Physicians; 2007.
- Lode H, Kemmerich B, Koeppe P. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin. Antimicrob Agents Chemother 1975;8:396–401.
- Pechere JC, Dugal R, Pechere MM. Kinetics of netilmicin in man. Clin Pharmacol Ther 1978;23:677–84.
- Teigen MM, Duffull S, Dang L, Johnson DW. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. J Clin Pharmacol 2006;46:1259–67.
- Kamel Mohamed OH, Wahba IM, Watnick S, Earle SB, Bennett WM, Ayres JW, . Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen. Clin J Am Soc Nephrol 2007;2: 694–9.
- Sowinski KM, Magner SJ, Lucksiri A, Scott MK, Hamburger RJ, Mueller BA. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing. Clin J Am Soc Nephrol 2008;3: 355–61.
- World Medical Association Inc. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc 2009;107:403–5.
- Dixon JR Jr. The International Conference on Harmonization Good Clinical Practice guideline. Qual Assur 1998;6: 65–74.
- Simon VK, Mosinger EU, Malerczy V. Pharmacokinetic studies of tobramycin and gentamicin. Antimicrob Agents Chemother 1973;3:445–50.
- Zaske DE, Cipolle RJ, Rotschafer JC, Solem LD, Mosier NR, Strate RG. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 1982;21:407–11.
- Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281–8.
- Williams AC. The role of pharmacodynamics in effective treatment of community-acquired pathogens. Advanced Studies in Medicine 2002;2:126–34.
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1–10; quiz 1–2.
- Ismail R, Sarriff A, Abdul Rahman AF. Therapeutic drug monitoring for gentamicin in Hospital Universiti Sains Malaysia. Med J Malaysia 1990;45:57–64.